Quick Takeaways
- Jean-Pierre Sommadossi filed SCHEDULE 13G/A for Atea Pharmaceuticals, Inc. Common Stock, par value $0.001 (AVIR).
- Disclosed ownership: 10%.
- Date of event: 31 Mar 2025.
Jean-Pierre Sommadossi - 31 Mar 2025 SCHEDULE 13G/A Report for Atea Pharmaceuticals, Inc. Common Stock, par value $0.001 (AVIR)
- Filing Manager
- Jean-Pierre Sommadossi
- Reporting Manager
- Jean-Pierre Sommadossi
- Symbol
- AVIR
- Shares outstanding
- 87,885,673 shares
- Disclosed Ownership
- 8,876,453 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 May 2025, 18:21:56 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Jean-Pierre Sommadossi disclosed 10% ownership in Atea Pharmaceuticals, Inc. Common Stock, par value $0.001 (AVIR) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 May 2025, 18:21.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JPM Partners LLC | 6.9% | 5,866,025 | 0 | 5,866,025 | /s/ Jean-Pierre Sommadossi | Jean-Pierre Sommadossi, Manager | |
| Jean-Pierre Sommadossi | 10% | 8,876,453 | 3,010,428 | 5,866,025 | Jean-Pierre Sommadossi | Jean-Pierre Sommadossi |